Iterum Therapeutics
Price & Volume
Stats
See more52W Range | $0.61-$3.02 |
Market Cap | $30.3M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | -100% |
Gross Profit (12 Mos) | -$941,000 |
Diluted EPS | -$0.81 |
News
See moreYahoo Finance • 4 days ago
Iterum Therapeutics Provides Business Update
Yahoo Finance • last month
Iterum Therapeutics launches ORLYNVAH™, the first and only oral penem antibiotic in the U.S.
Yahoo Finance • 2 months ago
Iterum Therapeutics PLC (NASDAQ:ITRM) Reports Wider Q2 2025 Loss, Market Optimistic Ahead of ORLYNVAH Launch
Yahoo Finance • 2 months ago
Iterum Therapeutics Reports Second Quarter 2025 Financial Results
About
CEO | Mr. Corey N. Fishman |
Address | 3 Dublin Landings, Dublin, Ireland, D01 C4E0 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 9 |
